Antibiotic Resistance Pattern of Uropathogenic Escherichia coli Identified in a Healthcare Laboratory (Morocco) http://www.doi.org/10.26538/tjnpr/v7i8.4
Article Sidebar
Main Article Content
Abstract
Urinary tract infection is one of the most common infectious diseases worldwide. This study aimed to determine the frequency of Urinary tract infections, identify the microorganisms involved, and determine the antibiotic resistance pattern of Escherichia coli. Conventional biochemical techniques identified isolates. The antibiogram was produced using the Muller-Hinton agar disc diffusion method according to the recommendations of the Antibiotic Committee of the French Microbiology Society. During the study period, 21. 4% of the samples were identified as positive. The microorganisms isolated were: Escherichia coli (47%), Klebsiella pneumoniae (19%) followed by Trichomonas vaginalis (9%), Candida albicans, and Pseudomonas sp (8%). Finally, Staphylococcus aureus and Proteus rettgeri represent 4% of isolates. The dominant resistance of E.coli was to amoxicillin and ticarcillin (55%) followed by cefalotine (39%). Resistance to fluoroquinolones was 27% (norfloxacin). The amikacin and gentamicin resistance rates were 12.5%, and 10.5% respectively. The resistance to the third-generation cephalosporins (ceftazidime, cefotaxime) was 10.5%. E. coli were resistant to nitrofurantoin and fosfomycin with percentages of 10.5%, and 6.6% respectively. However, the resistance to imipenem does not
exceed 2%. Increasing rates of E.coli antibiotic resistance indicate that careful monitoring of their use is necessary.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Marcon J, Stief CG, Magistro G. Urinary Tract Infections: What Has Been Confirmed in Therapy? Internist (Berl). 2017; 58(12):1242-1249.
Schappert SM and Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011; 13(169):1-38.
Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010; 7(12): 653-660.
Société de Pathologie Infectieuse de Langue Française. Second Consensus Conference on Anti-Infectious Therapeutics Antibiotherapy of Urinary Infections. Méd Mal Infect. 1991; 2: 51-54
Elkharrat D, Brun-Ney D, Cordier B et Goldstein F, Péan y, Sanson-Le-Pors MJ, Viso P.M, Zarka M, Debatisse A, Scheimberg A, Pecking M, pour le Groupe Vigil’Roc Urgences. Antimicrobial drugs prescribing in 34 French emergency departments. Méd Mal Infect. 2002 ; 33 (2) :70-77.
Chemlal A, Alami Ismaili F, Karimi I, AlHarraqui R, Benabdelleh N, Bekaoui S, Haddiya I, Bentata Y. Urinary tract infections in patients with chronic renal failure hospitalized in the nephrology department: bacteriological profile and risk factors.Pan Afr Med J. 2015;20(100).
EL Bakkouri J, Belabbes H, Zerouli K, Belaiche A, Messaouidi D, Claude JDP et Elmadaghri N. Antibiotic resistance of Escherichia coli community uropathogen and consumption of antibiotics in Casablanca (Morocco). Eur J Sci Res. 2009; 36(1):49-55.
Razine R, Azzouzi A, Barkat A, Khoudri I, Hassouni F, Chefchaouni AC, Abouqal R. Prevalence of hospitalacquired infections in the university medical center of Rabat, Morocco. Int Arch Med. 2012; 5 (1):26.
Sbiti M, Lahmadi K, Louzi L. Epidemiological profile of uropathogenic Enterobacteriaceae producing extendedspectrum beta-lactamases. Pan Afr Med J. 2017; 28(29):1-8
World Health Organization. 2017; consulted 04 April 2018. http://www.who.int/mediacentre/factsheets/antibioticresistance/fr.
Serwecińska L. Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health. Water. 2020; 12(12):3313.
Card KJ, Thomas MD, Graves JL Jr, Barrick JE, Lenski RE. Genomic evolution of antibiotic resistance is contingent on genetic background following a long-term experiment with Escherichia coli. Proc Natl Acad Sci USA. 2021; 118(5):e2016886118.
Kot B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Pol J Microbiol. 2019; 68(4):403–415.
Sakly H, Aouam A, Maarrakchi W, Kooli I, Toumi A, Ben Brahim, Chakroun M. Evolution of antibiotic resistance of uropathogenic Escherichia coli isolates at the Tunisian hospital from 2002 to 2017. J Infect Public Heal. 2020; 13(2):325.
Velazquez-Meza M E, Galarde-López M, Carrillo-Quiróz B, and Alpuche-Aranda CM. Antimicrobial resistance: One Health approach. Vet World. 2022; 15(3):743–749.
French Society of Microbiology. Antibiogram Committee of the French Society of Microbiology. 2018 consulted 1 May 2020. https://www.sfm-microbiologie.org/wp content/uploads/2018/12/CASFMV2_SEPTEMBRE2018.pdf.
Matuszkiewicz-Rowińska J, Małyszko J, and Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015; 11(1):67–77.
De Mouya D, Fabreb R, Cavalloble J D, le réseau AFORCOPI-BIO: Arzouni J-P, Baynat M, Bicart-See A, Berges J -L, Bouilloux J-P, Galinier J-L, Garrabé E, Gontier P, Grillet N, Lepargneur J-P, Naepels I, Payro G. Community-acquired urinary tract infections in 15 to 65-year-old female patients in France. Susceptibility of E. coli according to history: AFORCOPI-BIO network 2003. Méd Mal Infect. 2007; 3(9):594-598.
Vora S, Auchenthaler R. What does “extended-spectrum beta-lactamases” mean in practice? Rev Med Suisse. 2009; 5:1991-1994.
El bouamri MC, Arsalane L, Kamouni Y, Yahyaoui H, Bennouar N, Berraha M, Zouhair S. Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences. Prog Urol. 2014; 24(16):1058-1062.
Gonsu Kamga H, Nzengang R, Toukam M, Sando Z, Koulla Shiro S. Resistance phenotypes of Escherichia coli strains responsible for community urinary tract infections in the city of Yaounde (Cameron). Afri J Path Micro. 2014; 3: 1-4.
Guilemot D. Effect of antibiotic use on the evolution of bacterial resistance. Antibiotiques. 2001; 3(3):169–172.
Dizbay M, Ozger H. S, Karasahin O, and Karasahin E. F. Treatment efficacy and superinfection rates in complicated urinary tract infections treated with ertapenem or piperacillin tazobactam. Turk J Med Sci. 2016; 46:1760–1764.
Terlizzi M E, Gribaudo G and Maffei M E. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front Microbiol. 2017; 8: 1-23.
Abernethy J, Guy R, Sheridan EA, Hopkins S, Kiernan M, Wilcox MH, Johnson AP, Hope R. E. coli bacteraemia sentinel surveillance group. Epidemiology of Escherichia coli bacteremia in England: results of an enhanced sentinel surveillance program. J Hosp Infect. 2017; 95 (4): 365–375.
Faghri J, Dehbanipour R, Rastaghi S, Sedighi M, Maleki N. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016; 7 (1): 22–26.
Bonkat G, Pickard R, Bartoletti R, Bruyère F, Geerlings SE,et al: European Association of Urology. 2017; consulted 8 May 2020 https://uroweb.org/wpcontent/uploads/Urological-Infections-2017-pocket.pdf.
Tuem K.B, Desta R., Bitew H, Ibrahim S, Hishe H.Z. Antimicrobial resistance patterns of uropathogens isolated between 2012 and 2017 from a tertiary hospital in Northern Ethiopia. J Glob Antimicrob Resist. 2019; 18: 109-114.
Zhao L, Chen X, Zhu X, Yang W, Dong L, Xu X, Gao S, Gao S, Liu S. Prevalence of Virulence Factors and Antimicrobial Resistance of Uropathogenic Escherichia coli in Jiangsu Province (China). Urol. 2009; 74 (3): 702-7.
Batard E, Montassier E, Ballereau F, Potel G. From antibiotic consumption to bacterial resistance: the example of the resistance of Escherichia coli to quinolones. Med Ther. 2011 ; 17 (4) : 294-300.
Ali I, Rafaque Z, Ahmed S, Malik S, Dasti JI. Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed. 2016; 6(1):60–66.
Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJMárquez-Díaz F, Harel J, Guerrero-Barrera AL. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: crosssectional study. Ann Clin Microbiol Antimicrob. 2018; 17
(1):34.
Ciontea AS, Cristea D, Andrei MM, Popa A, Usein CR. In vitro antimicrobial resistance of urinary Escherichia coliisolates from outpatients collected in a laboratory during two years, 2015–2017. Roum Arch Microbiol Immunol. 2018; 77(1):28–32.7.
Lavigne JP, Thibault M, Costa P, Combescure C, Sotto A,Cariou G, Coloby P, Thibault M, Cariou G, Desplaces N, Costa P, Sotto A. Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre study. J Med Microbiol. 2016;65 (6):530–537.
Benhiba I, Bouzekraoui T, Zahid J, Elkhodri N, Ait Said L, Warda K, Zahlane K. Epidemiology and antibiotic resistance Enterobacteriaceae urinary of adult’s infections in Marrakech UHC and commitment therapy. Uro'Andro. 2015 ; 1(4) :166-171.